Lexaria Bioscience Submits Application to Health Canada for Research License and Appoints Chief Legal Officer

Tickers: XCNQ:LXX, XOTC:LXRP, PINX:LXRPTags: None Kelowna, British Columbia / TheNewswire / November 26, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces it has submitted a Health Canada research application,…